Originally identified as an anti-tumor drug, aclacinomycin A is the first described non-peptidic inhibitor showing discrete specificity for the chymotrypsin-like activity of the 20S proteasome. Aclacinomycin A has no effect on cathepsin B, it stimulates
Molecular Weight:
811.9
Purity:
95% (TLC)
CAS Number:
[57576-44-0]
Formula:
C42H53NO15
Target:
Proteasome 20S
* VAT and and shipping costs not included. Errors and price changes excepted